Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

SEC Censures JPMorgan With No Fine After a Disqualified Trader Handled 800 Swap Transactions Over Two Years

by Team Lumida
October 2, 2026
in Equities
Reading Time: 4 mins read
A A
0
SEC Censures JPMorgan With No Fine After a Disqualified Trader Handled 800 Swap Transactions Over Two Years
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • The SEC censured JPMorgan Chase and its securities unit in a cease-and-desist order issued Friday, alleging the firm failed to detect that one of its security-backed swaps traders had been fined by UK authorities and was not permitted to trade in the US without special relief. The lapse ran from late 2021 to early 2024.
  • No monetary penalty was imposed. The order cites the firm remedial efforts and its self-reporting of the apparent violation. JPMorgan did not admit the allegations and did not immediately respond to a request for comment.
  • Before the firm secured authorisation in March 2024, the trader executed 100 security-based swap transactions with or for US counterparties and supervised sales traders who carried out at least 700 more. The order states that no systems or supervisory procedures alerted JPMorgan that a statutorily disqualified person was effecting or supervising those transactions.
  • The underlying UK matter was mild. The regulator now known as the Financial Conduct Authority fined the unnamed employee in 2011 over a failure to report some customers potential insider trading, and said the conduct was neither deliberate nor reckless and that his integrity was not in question.

What Happened?

A sanction from a foreign regulator meant the individual should not have been authorised to trade in the US unless the firm obtained relief. JPMorgan secured that permission in March 2024, but according to the SEC nobody at the firm informed the trader or his supervisor that he could not transact until then.

Why It Matters?

The absence of a fine is the most useful information here. A supervisory failure spanning more than two years and roughly 800 transactions produced a censure and nothing more, with the SEC explicitly crediting self-reporting and remediation. For compliance functions weighing whether to disclose a discovered problem, that is a concrete precedent rather than a theoretical benefit, and it is worth citing internally. The mildness of the underlying conduct is the second lesson and the one most likely to catch other firms. A 2011 finding that the regulator itself described as neither deliberate nor reckless, with integrity not in question, nonetheless created a US statutory disqualification. Disqualification attaches to the existence of the finding, not to its severity, which means historic foreign regulatory actions that look trivial on their face can carry significant US consequences years later. Any broker-dealer employing staff with overseas regulatory histories has the same exposure. The specific control gap is identifiable and probably common. Nobody told the trader or his supervisor that he was disqualified, so the individual was unaware of his own status, which points to a failure in screening foreign regulatory actions at onboarding and monitoring them thereafter. That is a fixable systems problem rather than a cultural one. For shareholders this is immaterial, with the stock up 0.42% on the day and no penalty assessed. The value sits entirely in the precedent, both on enforcement posture toward self-reporters and on how far statutory disqualification reaches.

What Next?

Watch whether the SEC brings similar supervisory cases against other broker-dealers, since the issue described is systemic rather than firm-specific and the order effectively publishes the template. Whether subsequent cases also avoid penalties will show if the no-fine outcome reflects a durable policy toward self-reporting or the particular facts here, including the absence of any alleged harm to counterparties. Compliance teams should treat this as prompting a review of how foreign regulatory actions against employees are screened and monitored over time. Any guidance from the SEC on statutory disqualification arising from overseas sanctions would be the clearest follow-up, given how mild the triggering finding was in this instance.

Affected Tickers and Coins: JPM, GS, MS

Source: Bloomberg

Previous Post

Trump Says Europe Will Release Diesel Immediately, Making a US Export Ban Less Likely as Crude Falls to $89.75

Next Post

Goldman Earned More From Incentive Fees on Client SpaceX Stakes Than From the $100 Million IPO Mandate

Recommended For You

Novartis Inks Chinese mRNA-Therapy Deal; Abogen Biosciences $7.8B; ABO2203 Autoimmune T-Cell Engager; $575M Upfront; White Blood Cell Depletion; Novo Nordisk Jiangsu Hengrui $2.6B Obesity Pill; AstraZeneca Summit $2B Cancer; Chimagen GSK Blood-Cancer; Big Pharma China Drug Licensing Trend

by Team Lumida
8 hours ago
Novartis Inks Chinese mRNA-Therapy Deal; Abogen Biosciences $7.8B; ABO2203 Autoimmune T-Cell Engager; $575M Upfront; White Blood Cell Depletion; Novo Nordisk Jiangsu Hengrui $2.6B Obesity Pill; AstraZeneca Summit $2B Cancer; Chimagen GSK Blood-Cancer; Big Pharma China Drug Licensing Trend

Novartis AG licensing mRNA-based autoimmune therapy from China's Abogen Biosciences. Deal worth $7.8B (up to $7.2B additional milestones). $575M upfront for mRNA-encoded T-cell engager (ABO2203). Drug resets immune...

Read more

IG Group Holdings Stock Plunges 27%; Q3 Revenue Surprise Slump; £240M Q3 Sales -14% YoY; May Guidance Cut 10-15% to Mid-Single Digit; Over-the-Counter Revenue -18%; Customer Income +8%; Underdog Acquisition $1.3B July; Oct 22 Strategy Update

by Team Lumida
8 hours ago
IG Group Holdings Stock Plunges 27%; Q3 Revenue Surprise Slump; £240M Q3 Sales -14% YoY; May Guidance Cut 10-15% to Mid-Single Digit; Over-the-Counter Revenue -18%; Customer Income +8%; Underdog Acquisition $1.3B July; Oct 22 Strategy Update

IG Group Holdings Plc shares plummeted 27% (steepest intraday decline since Dec 2016). Q3 revenue expected £240M (~$317M)—14% drop vs prior year. Company cut 2026 guidance: expected mid-single...

Read more

Dyson’s $995 Million Dividend Reverses Years of Payouts; £750M Distribution Weybourne Holdings 2025; $19.7B Net Worth (UK #2); £6.1B Revenue -6.7% YoY; Operating Profit +15% £603M; AI Stain-Detection Robot; Singapore Headquarters; Family Office Diversification; Insurance Unit; Farming/Land Expansion; Jane Simpson CIO

by Team Lumida
8 hours ago
Dyson’s $995 Million Dividend Reverses Years of Payouts; £750M Distribution Weybourne Holdings 2025; $19.7B Net Worth (UK #2); £6.1B Revenue -6.7% YoY; Operating Profit +15% £603M; AI Stain-Detection Robot; Singapore Headquarters; Family Office Diversification; Insurance Unit; Farming/Land Expansion; Jane Simpson CIO

James Dyson's vacuum cleaner-maker ramped up annual dividend to billionaire's family holding company. £750M ($995M) distribution 2025 to Singapore-based Weybourne Holdings. Previous dividend 2024: £200M (lowest in 7...

Read more

New World Development Shares Fall Post Loss; HK$28.1B Loss ($3.6B); 11 Skies Exit HK$18.3B Write down; Third Annual Loss; HK$3B Airport Authority Payment; Three Towers/Entertainment Venue April Handover; White-Knight Investor Opportunity; Chow Tai Fook Support; Echo Huang CEO Balance Sheet Optimization; Blackstone Deal Scrapped

by Team Lumida
9 hours ago
New World Development Shares Fall Post Loss; HK$28.1B Loss ($3.6B); 11 Skies Exit HK$18.3B Write down; Third Annual Loss; HK$3B Airport Authority Payment; Three Towers/Entertainment Venue April Handover; White-Knight Investor Opportunity; Chow Tai Fook Support; Echo Huang CEO Balance Sheet Optimization; Blackstone Deal Scrapped

New World Development shares plummeted despite HK$28.1B ($3.6B) loss announcement. Stock jumped 10% early (11 Skies exit positive), fell 4% afternoon (broader Hong Kong selloff). HK$18.3B writedown for...

Read more

Firmus Grid Prices IPO A$11 Share; A$43.7B Valuation ($30.3B); A$5B Raise Australia; Oct 23 ASX Debut; Batam Indonesia Data Center; Nvidia Partnership 8-Year; Jane Street Blackstone Investment; Anthropic Mega IPO Pipeline; Moonshot $5B Hong Kong; Major Australian IPO; Bitcoin Mining 2019

by Team Lumida
9 hours ago
Firmus Grid Prices IPO A$11 Share; A$43.7B Valuation ($30.3B); A$5B Raise Australia; Oct 23 ASX Debut; Batam Indonesia Data Center; Nvidia Partnership 8-Year; Jane Street Blackstone Investment; Anthropic Mega IPO Pipeline; Moonshot $5B Hong Kong; Major Australian IPO; Bitcoin Mining 2019

Firmus Grid Ltd. priced IPO A$11/share; seeking A$5B+ Australian listing Oct 2026. Valuation A$43.7B ($30.3B USD)—below A$50B expectations. Bookbuild Oct 6-9; ASX debut Oct 23. Proceeds fund GPU...

Read more

Broadcom Amassing $60 Billion AI Chip Financing for Anthropic; $42B Class A Senior-Secured Banks; $18B Class B Junior Debt Blackstone $9B; Syndication Letters Sent; Nvidia $500B Partnership August; Hundreds of Billions AI Infrastructure Debt; Anthropic-Blackstone Fund Performance Boost; Data-Center Backlash Monitoring

by Team Lumida
9 hours ago
Broadcom Amassing $60 Billion AI Chip Financing for Anthropic; $42B Class A Senior-Secured Banks; $18B Class B Junior Debt Blackstone $9B; Syndication Letters Sent; Nvidia $500B Partnership August; Hundreds of Billions AI Infrastructure Debt; Anthropic-Blackstone Fund Performance Boost; Data-Center Backlash Monitoring

Broadcom gathering $60B fresh AI chip financing for Anthropic + others. $42B Class A senior-secured tranche (banks syndication letters). $18B Class B junior debt (Blackstone leading, $9B commitment...

Read more

EG Group Delays IPO Plans Until 2027; Draws Stonepeak Takeover Interest; TDR Capital 50% Owner; Issa Brothers 25% Each; $1B Raise Target $9B Valuation Failed; $5.8B Debt; $4B Q1 Revenue; Asda Portfolio Sale; JET Tankstellen/Castrol Stonepeak Precedent; IPO Market Conditions Difficult

by Team Lumida
9 hours ago
EG Group Delays IPO Plans Until 2027; Draws Stonepeak Takeover Interest; TDR Capital 50% Owner; Issa Brothers 25% Each; $1B Raise Target $9B Valuation Failed; $5.8B Debt; $4B Q1 Revenue; Asda Portfolio Sale; JET Tankstellen/Castrol Stonepeak Precedent; IPO Market Conditions Difficult

EG Group delaying IPO until 2027; receives takeover interest from Stonepeak (infrastructure). 50% TDR Capital; 25% each Mohsin/Zuber Issa. Originally planned NYSE listing autumn 2026 under Cumberland Farms...

Read more

Amazon Seeks to Offload $8B Nvidia Chips to Investors; Grace Blackwell SPV Strategy; Asset-Light Balance Sheet; $220B Capex 2026; AWS Data Centers US; Residual Value Guarantees; Investment-Grade Rating Expected; Nvidia Vera Rubin Supersedes; CoreWeave Precedent; Nvidia $500B Financing Platform

by Team Lumida
9 hours ago
Amazon Seeks to Offload $8B Nvidia Chips to Investors; Grace Blackwell SPV Strategy; Asset-Light Balance Sheet; $220B Capex 2026; AWS Data Centers US; Residual Value Guarantees; Investment-Grade Rating Expected; Nvidia Vera Rubin Supersedes; CoreWeave Precedent; Nvidia $500B Financing Platform

Amazon seeking to offload ~$8B Nvidia Grace Blackwell chips to external investors via special-purpose vehicle (SPV). Chips deployed across 15+ US data centers (Nevada, Virginia, others). Amazon leases...

Read more

Judge Clears $3.2 Billion of Ad-Tech Damages Claims Against Google From 5,000 Publishers, USA Today and Daily Mail

by Team Lumida
24 hours ago
Judge Clears $3.2 Billion of Ad-Tech Damages Claims Against Google From 5,000 Publishers, USA Today and Daily Mail

The Virginia ruling found liability but ordered only interoperability. These suits are where the finding converts into cash.

Read more

Tesla Deliveries Seen Falling 7% to 463,761 While It Spends Over $25 Billion on Businesses Years From Affecting Margins

by Team Lumida
1 day ago
Tesla Deliveries Seen Falling 7% to 463,761 While It Spends Over $25 Billion on Businesses Years From Affecting Margins

European registrations are up 65.9% this year, driven by soaring petrol prices and cheaper Chinese EVs rather than anything Tesla has done.

Read more
Next Post
Goldman Earned More From Incentive Fees on Client SpaceX Stakes Than From the $100 Million IPO Mandate

Goldman Earned More From Incentive Fees on Client SpaceX Stakes Than From the $100 Million IPO Mandate

Tron Settles Up to $190 Billion of Stablecoins a Week on 27 Validators, and the Bull Case Rests on One Issuer

Peirce Leaves the SEC With Two Commissioners Remaining and a New Rule Letting the Agency Operate With One

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China Stimulus: Enough to Sway Markets?

Google Revenue Surges on AI and Cloud Growth

July 24, 2025
OpenAI Hack: Why AI Companies Are Prime Targets for Cyberattacks

OpenAI to Open First Office in India as It Expands Presence in Key Market

August 22, 2025
a gas pump is connected to a car at a gas station

Gas Prices Are Wiping Out Wage Gains — Real Hourly Earnings Turn Negative for First Time Since 2023

May 13, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018